secwatch.observer — SEC 8-K summary
======================================

Issuer:     HEALTHEQUITY, INC. (HQY)
CIK:        0001428336
Form:       8-K
Filed at:   2026-10-09T21:00:29+00:00
Accession:  0001104659-26-115084
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

HealthEquity CCO Michael Fiore terminated without cause, effective Oct 5, 2026; no successor named
--------------------------------------------------------------------------------

- Michael Fiore, Chief Commercial Officer of HealthEquity, was terminated by the company without cause, effective October 5, 2026.
- The Chief Commercial Officer responsibilities will be redistributed to other members of HealthEquity's management team; no replacement was named.
- Fiore will receive previously negotiated severance payments and benefits under his employment agreement, as detailed in the company's proxy statement filed May 13, 2026.
- Severance is conditioned on a release of claims against the company and continued compliance with restrictive covenants in his employment agreement.
- Outstanding equity awards will be treated consistent with HealthEquity's 2014 and 2024 Stock Incentive Plans and his applicable award agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1428336/000110465926115084/0001104659-26-115084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1428336/000110465926115084/tm2627329d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-115084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer